Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is NuVasive, Inc. (NUVA) A Good Stock To Buy?

Page 1 of 2

The third quarter was a rough one for most investors, as fears of an interest rate hike in the U.S, a weakening economy in China, and a stagnant Europe, weighed heavily on the minds of investors. Both the S&P 500 and Russell 2000 sank as a result, with the Russell 2000, which is composed of smaller companies, being hit especially hard. This was primarily due to hedge funds, which are big supporters of small-cap stocks, pulling some of their capital out of the volatile markets during this time. Let’s look at how this market volatility affected the sentiment of hedge funds towards NuVasive, Inc. (NASDAQ:NUVA) , and what that likely means for the prospects of the company and its stock.

NuVasive, Inc. (NASDAQ:NUVA) investors should be aware of an increase in enthusiasm from smart money in recent months. At the end of this article, we will also compare NuVasive, Inc. (NASDAQ:NUVA) to other stocks, including HRG Group Inc (NYSE:HRG), Laclede Group Inc (NYSE:LG), and Cantel Medical Corp. (NYSE:CMN) to get a better sense of its popularity.

Follow Nuvasive Inc (NASDAQ:NUVA)
Trade (NASDAQ:NUVA) Now!

To most investors, hedge funds are assumed to be underperforming, outdated investment tools of yesteryear. While there are over 8000 funds in operation at the moment, We choose to focus on the bigwigs of this club, about 700 funds. These investment experts handle the bulk of the smart money’s total capital, and by monitoring their best picks, Insider Monkey has figured out a few investment strategies that have historically defeated Mr. Market. Insider Monkey’s small-cap hedge fund strategy outstripped the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, we’re going to view the recent action regarding NuVasive, Inc. (NASDAQ:NUVA).

What does the smart money think about NuVasive, Inc. (NASDAQ:NUVA)?

At the end of September, a total of 37 of the hedge funds tracked by Insider Monkey were bullish on this stock, an increase of 3% from the second quarter. With the smart money’s capital changing hands, there exists a few key hedge fund managers who were upping their stakes considerably (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Millennium Management, managed by Israel Englander, holds the largest position in NuVasive, Inc. (NASDAQ:NUVA). Millennium Management has a $83.9 million position in the stock, comprising 0.2% of its 13F portfolio. Sitting at the No. 2 spot is Blue Mountain Capital, led by Andrew Feldstein and Stephen Siderow, holding a $80.1 million position; the fund has 1.5% of its 13F portfolio invested in the stock. Some other peers that are bullish comprise Samuel Isaly’s OrbiMed Advisors, Ken Fisher’s Fisher Asset Management, and Anand Parekh’s Alyeska Investment Group.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!